Drug Profile
SYN 200
Alternative Names: SYN-200Latest Information Update: 14 Oct 2022
Price :
$50
*
At a glance
- Originator Synthetic Biologics
- Developer Theriva Biologics
- Class Peptide hormones; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Phenylketonuria